Trial Profile
Comparison of Medication Adherence Between Once Daily Tacrolimus (Advagraf) and Twice Daily Tacrolimus (Prograf) Administration in Stable Renal Transplant Recipients - a Randomized Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 May 2018
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 14 May 2018 Status changed from active, no longer recruiting to completed.
- 19 Apr 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 19 Apr 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.